Questions people ask about APOE Basis

The APOE ε4 allele (rs429358, rs7412) is the strongest common genetic risk factor for late-onset Alzheimer's disease. Carriers of one ε4 copy have a 3- to 4-fold increased risk; two copies raise risk 10- to 12-fold. However, ε4 is neither necessary nor sufficient for Alzheimer's – many ε4 carriers never develop dementia, and many Alzheimer's patients lack ε4. The ε2 allele is protective. Regarding diet, some observational studies suggest ε4 carriers may benefit from lower saturated fat intake, but randomized controlled trials have not confirmed a genotype-specific diet effect. Evidence for gene-diet interactions is moderate at best, and current guidelines do not recommend APOE-based dietary prescriptions. Predictive APOE testing in asymptomatic individuals is discouraged by many medical societies due to limited predictive value and potential psychological harm. Testing is used in research and for specific clinical contexts (e.g., evaluating memory complaints). Overall, APOE ε4 is a well-established risk factor, but lifestyle factors such as exercise, cognitive engagement, and cardiovascular health can modulate risk. The variant is common (≈15–20% of Europeans carry ε4) and its effect is probabilistic, not deterministic.